Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer

Advances in Doxorubicin-based nano-drug delivery system in triple negative breast cancer

Triple negative breast cancer (TNBC) is one of the most aggressive breast cancer. Due to the unique cell phenotype, aggressiveness, metastatic potential and lack of receptors or targets, chemotherapy is the choice of treatment for TNBC. Doxorubicin (DOX), one of the representative agents of anthracy...

Full description

Saved in:
Bibliographic Details
Main Authors: Weiwei Zeng, Yuning Luo, Dali Gan, Yaofeng Zhang, Huan Deng, Guohui Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
doxorubicin
nanocarriers
triple negative breast cancer
drug delivery
clinical
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1271420/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items